...
首页> 外文期刊>BMC Biotechnology >Development of an efficient, non-viral transfection method for studying gene function and bone growth in human primary cranial suture mesenchymal cells reveals that the cells respond to BMP2 and BMP3
【24h】

Development of an efficient, non-viral transfection method for studying gene function and bone growth in human primary cranial suture mesenchymal cells reveals that the cells respond to BMP2 and BMP3

机译:研究人类原发性颅骨缝线间充质细胞基因功能和骨骼生长的有效,非病毒转染方法的开发揭示了该细胞对BMP2和BMP3有反应

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Achieving efficient introduction of plasmid DNA into primary cultures of mammalian cells is a common problem in biomedical research. Human primary cranial suture cells are derived from the connective mesenchymal tissue between the bone forming regions at the edges of the calvarial plates of the skull. Typically they are referred to as suture mesenchymal cells and are a heterogeneous population responsible for driving the rapid skull growth that occurs in utero and postnatally. To better understand the molecular mechanisms involved in skull growth, and in abnormal growth conditions, such as craniosynostosis, caused by premature bony fusion, it is essential to be able to easily introduce genes into primary bone forming cells to study their function. Results A comparison of several lipid-based techniques with two electroporation-based techniques demonstrated that the electroporation method known as nucleofection produced the best transfection efficiency. The parameters of nucleofection, including cell number, amount of DNA and nucleofection program, were optimized for transfection efficiency and cell survival. Two different genes and two promoter reporter vectors were used to validate the nucleofection method and the responses of human primary suture mesenchymal cells by fluorescence microscopy, RT-PCR and the dual luciferase assay. Quantification of bone morphogenetic protein (BMP) signalling using luciferase reporters demonstrated robust responses of the cells to both osteogenic BMP2 and to the anti-osteogenic BMP3. Conclusions A nucleofection protocol has been developed that provides a simple and efficient, non-viral alternative method for in vitro studies of gene and protein function in human skull growth. Human primary suture mesenchymal cells exhibit robust responses to BMP2 and BMP3, and thus nucleofection can be a valuable method for studying the potential competing action of these two bone growth factors in a model system of cranial bone growth.
机译:背景技术将质粒DNA有效地导入哺乳动物细胞的原代培养是生物医学研究中的普遍问题。人的头颅缝合线细胞来源于颅骨颅骨边缘边缘的骨形成区域之间的结缔组织。通常,它们被称为缝合间充质细胞,是负责驱动子宫内和产后颅骨快速生长的异质种群。为了更好地了解与骨骼生长有关的骨骼机制,以及在骨骼过早融合引起的异常颅骨生长等异常生长条件下所涉及的分子机制,必须能够轻松地将基因引入初级骨形成细胞以研究其功能,这一点至关重要。结果几种基于脂质的技术与两种基于电穿孔的技术的比较表明,被称为核转染的电穿孔方法产生了最佳的转染效率。优化了核转染的参数,包括细胞数量,DNA量和核转染程序,以提高转染效率和细胞存活率。使用两种不同的基因和两种启动子报告载体,通过荧光显微镜,RT-PCR和双重荧光素酶法验证了核转染方法和人原代缝合线间充质细胞的反应。使用荧光素酶报道分子对骨形态发生蛋白(BMP)信号的定量显示,细胞对成骨性BMP2和抗成骨性BMP3都有很强的反应。结论已开发出一种核转染方案,该方案为体外研究人类颅骨生长中的基因和蛋白质功能提供了一种简单有效的非病毒替代方法。人类原缝线间充质细胞对BMP2和BMP3表现出强大的反应,因此核转染可能是研究颅骨生长模型系统中这两种骨生长因子潜在竞争作用的有价值的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号